Three-year outcome in a patient with Staphylococcus lugdunensis discitis

Joint Bone Spine. 2002 Jan;69(1):85-7. doi: 10.1016/s1297-319x(01)00348-7.

Abstract

The few reported cases of bone and joint infection by Staphylococcus lugdunensis indicate that the clinical manifestations are severe, the diagnosis elusive, and the treatment difficult. We report a case of lumbar discitis caused by Staphylococcus lugdunensis in a 67-year-old man receiving chemotherapy for stage III IgA lambda multiple myeloma. Treatment was with ofloxacin and pristinamycin for 1 year. Although he started to improve only 5 months after treatment initiation, the outcome was favorable. Follow-up at the time of this writing is 3 years.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Discitis / drug therapy
  • Discitis / etiology
  • Discitis / pathology*
  • Humans
  • Immunocompromised Host
  • Lumbar Vertebrae / microbiology
  • Lumbar Vertebrae / pathology*
  • Male
  • Microbial Sensitivity Tests
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / immunology
  • Ofloxacin / therapeutic use
  • Pristinamycin / therapeutic use
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / pathology*
  • Staphylococcus / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Pristinamycin
  • Ofloxacin